1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Cipla Inc.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- Johnson and Johnson Inc.
- JUUL Labs Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the smoking cessation and nicotine de-addiction market and it is poised to grow by $ 18.01 bn during 2021-2025, progressing at a CAGR of 11.59% during the forecast period. The report on the smoking cessation and nicotine de-addiction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by new product launches and increasing number of people trying to quit smoking.
The smoking cessation and nicotine de-addiction market analysis includes the product segment and geographic landscape.
This study identifies the growing health awareness among consumers about harmful effects of cigars as one of the prime reasons driving the smoking cessation and nicotine de-addiction market growth during the next few years.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smoking cessation and nicotine de-addiction market vendors that include British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc. Also, the smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by new product launches and increasing number of people trying to quit smoking.
The smoking cessation and nicotine de-addiction market analysis includes the product segment and geographic landscape.
The smoking cessation and nicotine de-addiction market is segmented as below:
By Product
- e-cigarette
- NRT
- drug therapy
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- MEA
This study identifies the growing health awareness among consumers about harmful effects of cigars as one of the prime reasons driving the smoking cessation and nicotine de-addiction market growth during the next few years.
The report on smoking cessation and nicotine de-addiction market covers the following areas:
- Smoking cessation and nicotine de-addiction market sizing
- Smoking cessation and nicotine de-addiction market forecast
- Smoking cessation and nicotine de-addiction market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smoking cessation and nicotine de-addiction market vendors that include British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc. Also, the smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cipla Inc.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- Johnson and Johnson Inc.
- JUUL Labs Inc.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cipla Inc.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- Johnson and Johnson Inc.
- JUUL Labs Inc.
The publisher recognizes the following companies as the key players in the global smoking cessation and nicotine de-addiction market: British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc.
Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing health awareness among consumers about harmful effects of cigars.`
According to the report, one of the major drivers for this market is the new product launch.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing health awareness among consumers about harmful effects of cigars.`
According to the report, one of the major drivers for this market is the new product launch.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- British American Tobacco Plc
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- Johnson and Johnson Inc.
- JUUL Labs Inc.
- Pfizer Inc.
- Philip Morris International Inc.
Note: Product cover images may vary from those shown